Loading…
cited_by cdi_FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693
cites cdi_FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693
container_end_page 494
container_issue 2
container_start_page 494
container_title European urology
container_volume 52
creator Pizzocaro, Giorgio
description
doi_str_mv 10.1016/j.eururo.2007.02.007
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70655021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283807002114</els_id><sourcerecordid>70655021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693</originalsourceid><addsrcrecordid>eNqFkVFL5DAUhYO46Ky7_0CkT761e5NM2okPghR1F2UVdvc5pMkdTG2bMWkH5t9vygwIvvh0SDjnJPe7hJxTKCjQ8kdb4BSm4AsGUBXAiiRHZEFXFc8rUcIxWQAHlrMVX52SrzG2AMCF5CfklFaclrIUC_Jwa93og9NdVvu-x2HM_HCV_UavbTttdTrXL9j78QWD3uwyN2Q3Nl0btNkzDq7DrNbBuMH3-hv5stZdxO8HPSP_7m7_1j_zx6f7X_XNY244hzFnwCwtgbGmWbLSSDH_i3PBBJNcal41KNes0ZZqaZZSomxkQ42wwnCrS8nPyOW-dxP824RxVL2LBrtOD-inqCoohQBGk3G5N5rgYwy4Vpvgeh12ioKaIapW7SGqGaICppKk2MWhf2p6tO-hA7VkuN4bME25dRhUNA5nJi6gGZX17rMXPhaYzg3O6O4VdxhbP4UhEVRUxRRQf-ZFznuECtJcdMn_A9KlmOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70655021</pqid></control><display><type>article</type><title>Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma</title><source>Elsevier</source><creator>Pizzocaro, Giorgio</creator><creatorcontrib>Pizzocaro, Giorgio</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2007.02.007</identifier><identifier>PMID: 17316965</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bleomycin - administration &amp; dosage ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Cisplatin - administration &amp; dosage ; Fluorouracil - administration &amp; dosage ; Humans ; Male ; Methotrexate - administration &amp; dosage ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Penile Neoplasms - drug therapy ; Penile Neoplasms - pathology ; Penile Neoplasms - surgery ; Treatment Outcome ; Urology ; Vincristine - administration &amp; dosage</subject><ispartof>European urology, 2007-08, Vol.52 (2), p.494-494</ispartof><rights>European Association of Urology</rights><rights>2007 European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693</citedby><cites>FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17316965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pizzocaro, Giorgio</creatorcontrib><title>Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bleomycin - administration &amp; dosage</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Cisplatin - administration &amp; dosage</subject><subject>Fluorouracil - administration &amp; dosage</subject><subject>Humans</subject><subject>Male</subject><subject>Methotrexate - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Penile Neoplasms - drug therapy</subject><subject>Penile Neoplasms - pathology</subject><subject>Penile Neoplasms - surgery</subject><subject>Treatment Outcome</subject><subject>Urology</subject><subject>Vincristine - administration &amp; dosage</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkVFL5DAUhYO46Ky7_0CkT761e5NM2okPghR1F2UVdvc5pMkdTG2bMWkH5t9vygwIvvh0SDjnJPe7hJxTKCjQ8kdb4BSm4AsGUBXAiiRHZEFXFc8rUcIxWQAHlrMVX52SrzG2AMCF5CfklFaclrIUC_Jwa93og9NdVvu-x2HM_HCV_UavbTttdTrXL9j78QWD3uwyN2Q3Nl0btNkzDq7DrNbBuMH3-hv5stZdxO8HPSP_7m7_1j_zx6f7X_XNY244hzFnwCwtgbGmWbLSSDH_i3PBBJNcal41KNes0ZZqaZZSomxkQ42wwnCrS8nPyOW-dxP824RxVL2LBrtOD-inqCoohQBGk3G5N5rgYwy4Vpvgeh12ioKaIapW7SGqGaICppKk2MWhf2p6tO-hA7VkuN4bME25dRhUNA5nJi6gGZX17rMXPhaYzg3O6O4VdxhbP4UhEVRUxRRQf-ZFznuECtJcdMn_A9KlmOw</recordid><startdate>200708</startdate><enddate>200708</enddate><creator>Pizzocaro, Giorgio</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200708</creationdate><title>Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma</title><author>Pizzocaro, Giorgio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bleomycin - administration &amp; dosage</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Cisplatin - administration &amp; dosage</topic><topic>Fluorouracil - administration &amp; dosage</topic><topic>Humans</topic><topic>Male</topic><topic>Methotrexate - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Penile Neoplasms - drug therapy</topic><topic>Penile Neoplasms - pathology</topic><topic>Penile Neoplasms - surgery</topic><topic>Treatment Outcome</topic><topic>Urology</topic><topic>Vincristine - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pizzocaro, Giorgio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pizzocaro, Giorgio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2007-08</date><risdate>2007</risdate><volume>52</volume><issue>2</issue><spage>494</spage><epage>494</epage><pages>494-494</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>17316965</pmid><doi>10.1016/j.eururo.2007.02.007</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2007-08, Vol.52 (2), p.494-494
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_70655021
source Elsevier
subjects Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bleomycin - administration & dosage
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Cisplatin - administration & dosage
Fluorouracil - administration & dosage
Humans
Male
Methotrexate - administration & dosage
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasm Staging
Penile Neoplasms - drug therapy
Penile Neoplasms - pathology
Penile Neoplasms - surgery
Treatment Outcome
Urology
Vincristine - administration & dosage
title Editorial Comment on: Neoadjuvant Chemotherapy in Advanced Penile Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A00%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20Comment%20on:%20Neoadjuvant%20Chemotherapy%20in%20Advanced%20Penile%20Carcinoma&rft.jtitle=European%20urology&rft.au=Pizzocaro,%20Giorgio&rft.date=2007-08&rft.volume=52&rft.issue=2&rft.spage=494&rft.epage=494&rft.pages=494-494&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2007.02.007&rft_dat=%3Cproquest_cross%3E70655021%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c330t-202d16022bb426c950003335252939a37be9f2bad1a9c499e9b9b1c5d5c3da693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70655021&rft_id=info:pmid/17316965&rfr_iscdi=true